Overview

Repeat Dose Safety Study for Compound to Treat Asthma

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the safety and tolerability of single and repeat oral doses of GSK1440115 in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Accenture